- Patent Number: EP 3082455 B1 (2018.08.08)
- Application Number: 2014-820785 (2014.12.12)
- Priority Number: EP 2013-197197 (2013.12.13)
- Critical Date: December 13, 2013
- Title: USE OF A SWEET WHEY CONTAINING INFANT FORMULA FOR PROMOTING THE POSTNATAL NEURONAL DEVELOPMENT OF THE INFANT GASTROINTESTINAL TRACT, AND THE ESTABLISHMENT OF THE INTESTINAL FUNCTIONS THAT IT CONTROLS
- Assignee: SOCIETE DES PRODUITS NESTLE S.A.
- Search Request:
- This patent is directed to the use of sweet whey protein for preventing/treating disorders that are associated with an immature enteric nervous system. The enteric nervous system is that part of the nervous system that is connected to the digestive tract, such as the part that controls the stomach and intestines.
- Some of the disorders the patent describes that would be encompassed by the claims include: slow intestinal transit, intestinal discomfort, hard stools, constipation and/or gastrointestinal reflux (aka spit-up or regurgitation).
- Search for the specific proteins in sweet whey for the claimed uses, including α-lactalbumin, β-lactoglobulin, serum albumin, immunoglobulins and lactoferrin.
Invalidity Search Report for EP3082455B1
SKU: IPR2024-00003
$1,800.00Price